Abstract Glioblastoma (GBM) is one of the deadliest brain cancers with a median survival of only 15 months. This poor prognosis has prompted exploration of novel therapeutic targets for GBM patients. Human cytomegalovirus (HCMV) has been implicated in GBM; however. its impact remains poorly defined. https://www.nacrack.com/quick-grab-Chainsaw-File-super-grab/